Your browser doesn't support javascript.
loading
Use of botulinum toxin in Meige's disease.
Maurri, S; Brogelli, S; Alfieri, G; Barontini, F.
Afiliação
  • Maurri S; Cattedra di Neuropatologia e Psicopatologia, Istituto delle Malattie Nervose e Mentali, Università, Firenze.
Riv Neurol ; 58(6): 245-8, 1988.
Article em En | MEDLINE | ID: mdl-3247565
Four patients with severe Meige's disease (blepharospasm-oromandibular dystonia) have been treated, after having given an informed consent, by local injections of purified botulinum toxin type "A". Previous systemic therapy with anticholinergics, dopamine antagonists and other drugs had been unsuccessful in all these subjects. Each patient was treated by saline solution injected with the same method as botulinum toxin, just once. The self-evaluation of patients and the clinical evaluation that some of us- unaware of the kind of therapy which had been performed- gave to the symptoms on the basis of videotapes, for each session of injection, showed that the injections of botulinum toxin are effective in the treatment of such disorder. The duration of the beneficial effect was slightly shorter in these patients than in patients with blepharospasm treated by the same method.
Assuntos
Buscar no Google
Bases de dados: MEDLINE Assunto principal: Doenças dos Gânglios da Base / Toxinas Botulínicas / Síndrome de Meige Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Riv Neurol Ano de publicação: 1988 Tipo de documento: Article
Buscar no Google
Bases de dados: MEDLINE Assunto principal: Doenças dos Gânglios da Base / Toxinas Botulínicas / Síndrome de Meige Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Riv Neurol Ano de publicação: 1988 Tipo de documento: Article